Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
Part of paid clinical trials in Albuquerque, New Mexico.
- Sponsor
- Foundation for Advancing Veterans' Health Research
- Study ID
- NCT06333990
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Mild Traumatic Brain Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Quetiapine Fumarate — DRUGQuetiapine is an atypical antipsychotic approved by the FDA for the treatment of schizophrenia, bipolar disorder, and as an adjunct to treat major depression. It has a broad spectrum of actions at dopaminergic (D1, D2, D3 and D4), serotonergic (5-HT2A, 5-HT2C and 5-HT7), adrenergic (α1), histaminic (H1) and muscarinic (mACh), and partial agonist at 5-HT1A receptors.
- TAU — DRUGStandard of care psychotropic medications for treatment of patients with mTBI.
Study Details
A two site, 2-arm, Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU) medication management for symptoms experienced by veterans receiving rehabilitation therapy for mild traumatic brain injury (mTBI) and comorbid symptoms of posttraumatic stress disorder (PTSD).
Key Dates
- Start date
- Jul 9, 2024
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 146 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: QuetiapineQuetiapine will be cross-tapered up to a maximum dose of 200 mg (as tolerated) as other standard of care medications are discontinued.
- Active Comparator: Treatment As Usual (TAU)Participants in the TAU group will have doses adjusted over the same period as indicated by usual care criteria.
Primary Outcome Measure
Neurobehavioral Symptom Inventory [ Time Frame: 2 weeks ]
Central Contacts
- Muhammad R Baig, MD210-617-5300
- Lizette Aviles, BS361-277-5486
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New Mexico VA Healthcare System | Albuquerque | New Mexico | 87108 | |
| South Texas Veterans Healthcare System | San Antonio | Texas | 78229 | Suchada Hill |
Find similar trials in Albuquerque, NM
Related Studies
- Neuromodulation and Neurorehabilitation for mTBIRecruiting · Northwestern University · Chicago, Illinois
- Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)PHASE3 · Recruiting · VA Office of Research and Development · Birmingham, Alabama
- Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBIPHASE2 · Recruiting · Henry M. Jackson Foundation for the Advancement of Military Medicine · Fort Bragg, North Carolina
- rTMS for Military TBI-related DepressionRecruiting · Henry M. Jackson Foundation for the Advancement of Military Medicine · Palo Alto, California